Showing 8651-8660 of 21414 results for "".
Interchangeability and Biologics, Biosimilars, and Generics
https://reachmd.com/programs/clinicians-roundtable/interchangeability-and-biologics-biosimilars-and-generics/15987/With the ever-changing landscape of treatments, there are biosimilars for diabetes, inflammatory conditions, and cancers. Read more.Keys to Closing the Gender Gap in Stroke Trials
https://reachmd.com/programs/neurofrontiers/keys-to-closing-the-gender-gap-in-stroke-trials/13461/Why are women underrepresented in stroke trials, and what can be done to reverse this troubling trend?Health Care: Public Policy vs. Insiders Views
https://reachmd.com/programs/clinicians-roundtable/health-care-public-policy-vs-insiders-views/1088/Physicians ask, “What do I need to do right now for this specific patient today to maintain health.” Public Policy advocates ask, “What do we need to do in the future to ensure the health of our society.” How do we reconcile these different viewpoints to become a healthier nation?Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
https://reachmd.com/programs/cme/patient-at-high-risk-of-loss-to-follow-up-part-of-the-focused-sight-initiative-quality-improvement-interventions-in-retinal-disease/37711/Explore a case of severe diabetic macular edema and strategies for engaging busy, working-age patients in ongoing anti-VEGF therapy and follow-up care.Anti-inflammatory, Anti-atherogenic and Cardioprotective Effects of Insulin
https://reachmd.com/programs/diabetes-discourse/anti-inflammatory-anti-atherogenic-and-cardioprotective-effects-of-insulin/6691/Host Dr. Farhad Zangeneh welcomes Paresh Dandona MD, PhD, Professor and Chief of Endocrinology in the Department of Medicine at the University of Buffalo. His Specialty and Research Focus are in Endocrinology, Diabetes and Metabolism. He is also the Founder & Medical Director of the Diabetes-EnPCOS: The Challenge of Diagnosis and Medical Risk
https://reachmd.com/programs/advances-in-womens-health/pcos-the-challenge-of-diagnosis-and-medical-risk/1878/Polycystic ovary syndrome (PCOS) imperils reproductive age women, posing pressing concerns about fertility, and increasing risk of diabetes, heart disease, and endometrial cancer. Dr. Sam Thatcher, director of the multi-site Center for Applied Reproductive Science, considers the mechanisms of PCOS iBuilding Bone Vitality Without Dairy, Calcium, Estrogen, or Drugs: Is It Nutritionally Possible?
https://reachmd.com/programs/nutritionedge/building-bone-vitality-without-dairy-calcium-estrogen-drugs-nutritionally-possible/8461/Dr. Amy Lanou talks about a different nutritional approach to preventing bone loss and reversing osteoporosis.Pharmacologic Management of Behavioral Challenges and Psychiatric Comorbidities in People With Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/pharmacologic-management-of-behavioral-challenges-and-psychiatric-comorbidities-in-people-with-epilepsy/39969/Treatment of behavioral and psychiatric comorbidities in people with epilepsy requires careful consideration of underlying causes, symptom profile, antiseizure medications, and epilepsy type.Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
https://reachmd.com/programs/project-oncology/refining-multimodal-therapy-for-mesothelioma-clinical-impact-of-smart-sequencing/36559/Surgery for mesothelioma after radiation therapy (SMART) offers new hope for patients with resectable epithelioid mesothelioma by reversing the traditional treatment sequence. Hear from Dr. John Cho as he discusses the rationale behind this decade-long clinical advancement, which he spoke about at tCurrent Inquiries in Lipidology: The NLA's Role in the Field
https://reachmd.com/programs/lipid-luminations/current-inquiries-in-lipidology-the-nlas-role-in-the-field/6297/From reversing atherosclerosis with HDL modification to promising antibodies on the horizon for lowering LDL cholesterol, the science of lipidology is a quickly-evolving field. What is the role of the National Lipid Association in clinical practice for clinicians who may not be lipid specialists? H